• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于全基因组序列的长双歧杆菌 JDM301 的安全性评估。

Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences.

机构信息

Department of Medical Microbiology and Parasitology, Institutes of Medical Sciences, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.

出版信息

World J Gastroenterol. 2012 Feb 7;18(5):479-88. doi: 10.3748/wjg.v18.i5.479.

DOI:10.3748/wjg.v18.i5.479
PMID:22346255
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3270512/
Abstract

AIM

To assess the safety of Bifidobacterium longum (B. longum) JDM301 based on complete genome sequences.

METHODS

The complete genome sequences of JDM301 were determined using the GS 20 system. Putative virulence factors, putative antibiotic resistance genes and genes encoding enzymes responsible for harmful metabolites were identified by blast with virulence factors database, antibiotic resistance genes database and genes associated with harmful metabolites in previous reports. Minimum inhibitory concentration of 16 common antimicrobial agents was evaluated by E-test.

RESULTS

JDM301 was shown to contain 36 genes associated with antibiotic resistance, 5 enzymes related to harmful metabolites and 162 nonspecific virulence factors mainly associated with transcriptional regulation, adhesion, sugar and amino acid transport. B. longum JDM301 was intrinsically resistant to ciprofloxacin, amikacin, gentamicin and streptomycin and susceptible to vancomycin, amoxicillin, cephalothin, chloramphenicol, erythromycin, ampicillin, cefotaxime, rifampicin, imipenem and trimethoprim-sulphamethoxazol. JDM301 was moderately resistant to bacitracin, while an earlier study showed that bifidobacteria were susceptible to this antibiotic. A tetracycline resistance gene with the risk of transfer was found in JDM301, which needs to be experimentally validated.

CONCLUSION

The safety assessment of JDM301 using information derived from complete bacterial genome will contribute to a wider and deeper insight into the safety of probiotic bacteria.

摘要

目的

基于全基因组序列评估长双歧杆菌(B. longum)JDM301 的安全性。

方法

使用 GS 20 系统测定 JDM301 的全基因组序列。通过与先前报道的毒力因子数据库、抗生素耐药基因数据库和与有害代谢物相关的基因进行blast 分析,鉴定潜在的毒力因子、潜在的抗生素耐药基因和负责有害代谢物的编码酶。采用 E 试验评估 16 种常见抗菌药物的最小抑菌浓度。

结果

JDM301 含有 36 个与抗生素耐药相关的基因、5 个与有害代谢物相关的酶和 162 个非特异性毒力因子,主要与转录调控、黏附、糖和氨基酸转运有关。长双歧杆菌 JDM301 对环丙沙星、阿米卡星、庆大霉素和链霉素固有耐药,对万古霉素、阿莫西林、头孢噻吩、氯霉素、红霉素、氨苄西林、头孢噻肟、利福平、亚胺培南和复方磺胺甲噁唑敏感。JDM301 对杆菌肽中度耐药,而先前的研究表明双歧杆菌对该抗生素敏感。在 JDM301 中发现了一个具有转移风险的四环素耐药基因,需要进行实验验证。

结论

使用源自全细菌基因组的信息对 JDM301 进行安全性评估,有助于更广泛和深入地了解益生菌的安全性。

相似文献

1
Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences.基于全基因组序列的长双歧杆菌 JDM301 的安全性评估。
World J Gastroenterol. 2012 Feb 7;18(5):479-88. doi: 10.3748/wjg.v18.i5.479.
2
Safety Evaluations of BGN4 and BORI.BGN4 和 BORI 的安全性评估。
Int J Mol Sci. 2018 May 9;19(5):1422. doi: 10.3390/ijms19051422.
3
Antibiotic resistance of lactic acid bacteria and Bifidobacterium spp. isolated from dairy and pharmaceutical products.从乳制品和药品中分离出的乳酸菌和双歧杆菌属的抗生素抗性。
Int J Food Microbiol. 2007 Apr 1;115(1):35-42. doi: 10.1016/j.ijfoodmicro.2006.10.003. Epub 2007 Jan 2.
4
Complete genome sequence of Bifidobacterium longum JDM301.长双歧杆菌 JDM301 的全基因组序列。
J Bacteriol. 2010 Aug;192(15):4076-7. doi: 10.1128/JB.00538-10. Epub 2010 Jun 4.
5
Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.来自人类胃肠道的潜在益生菌双歧杆菌分离株的抗生素敏感性
Lett Appl Microbiol. 1998 May;26(5):333-7. doi: 10.1046/j.1472-765x.1998.00342.x.
6
Antibiotic Susceptibility Testing and Establishment of Tentative Species-Specific Microbiological Cut-off Values for Bifidobacteria Isolated from Chinese Population.来自中国人群的双歧杆菌的抗生素药敏试验和暂定种特异性微生物学截断值的建立。
Probiotics Antimicrob Proteins. 2024 Oct;16(5):1657-1672. doi: 10.1007/s12602-023-10128-9. Epub 2023 Jul 29.
7
Characterization of antimicrobial resistance in lactobacilli and bifidobacteria used as probiotics or starter cultures based on integration of phenotypic and in silico data.基于表型和计算机模拟数据整合对用作益生菌或发酵剂的乳杆菌和双歧杆菌的抗生素耐药性进行表征。
Int J Food Microbiol. 2020 Feb 2;314:108388. doi: 10.1016/j.ijfoodmicro.2019.108388. Epub 2019 Oct 24.
8
Antimicrobial susceptibility of Bifidobacterium strains from humans, animals and probiotic products.来自人类、动物和益生菌产品的双歧杆菌菌株的抗菌药敏性。
J Antimicrob Chemother. 2006 Jul;58(1):85-94. doi: 10.1093/jac/dkl197. Epub 2006 May 12.
9
Molecular characterisation of ABC-type multidrug efflux systems in Bifidobacterium longum.长双歧杆菌中ABC型多药外排系统的分子特征分析
Anaerobe. 2015 Apr;32:63-69. doi: 10.1016/j.anaerobe.2014.12.004. Epub 2014 Dec 18.
10
Bifidobacterium Bacteremia: Clinical Characteristics and a Genomic Approach To Assess Pathogenicity.双歧杆菌血症:临床特征及评估致病性的基因组学方法
J Clin Microbiol. 2017 Jul;55(7):2234-2248. doi: 10.1128/JCM.00150-17. Epub 2017 May 10.

引用本文的文献

1
The Genome of subsp. YLGB-1496 Provides Insights into Its Carbohydrate Utilization and Genetic Stability.亚种YLGB - 1496的基因组为其碳水化合物利用和遗传稳定性提供了见解。
Genes (Basel). 2024 Apr 8;15(4):466. doi: 10.3390/genes15040466.
2
Phylogenetic, Functional and Safety Features of 1950s Strains.20世纪50年代菌株的系统发育、功能及安全特性
Microorganisms. 2022 Jan 18;10(2):203. doi: 10.3390/microorganisms10020203.
3
Bifidobacterium adolescentis is intrinsically resistant to antitubercular drugs.青春双歧杆菌天然对抗结核药物具有耐药性。
Sci Rep. 2018 Aug 9;8(1):11897. doi: 10.1038/s41598-018-30429-2.
4
Safety Evaluation and Colonisation Abilities of Four Lactic Acid Bacteria as Future Probiotics.四种乳酸菌作为未来益生菌的安全性评估和定植能力。
Probiotics Antimicrob Proteins. 2019 Jun;11(2):397-402. doi: 10.1007/s12602-018-9430-y.
5
Safety Assessment of Lactobacillus helveticus KLDS1.8701 Based on Whole Genome Sequencing and Oral Toxicity Studies.基于全基因组测序和口服毒性研究的瑞士乳杆菌 KLDS1.8701 安全性评估。
Toxins (Basel). 2017 Sep 24;9(10):301. doi: 10.3390/toxins9100301.
6
Addressing the Antibiotic Resistance Problem with Probiotics: Reducing the Risk of Its Double-Edged Sword Effect.用益生菌解决抗生素耐药性问题:降低其双刃剑效应的风险。
Front Microbiol. 2016 Dec 15;7:1983. doi: 10.3389/fmicb.2016.01983. eCollection 2016.
7
Probiotic-based strategies for therapeutic and prophylactic use against multiple gastrointestinal diseases.基于益生菌的针对多种胃肠道疾病的治疗和预防策略。
Front Microbiol. 2015 Jul 14;6:685. doi: 10.3389/fmicb.2015.00685. eCollection 2015.
8
Feasibility of Genome-Wide Screening for Biosafety Assessment of Probiotics: A Case Study of Lactobacillus helveticus MTCC 5463.用于益生菌生物安全性评估的全基因组筛选的可行性:以瑞士乳杆菌MTCC 5463为例
Probiotics Antimicrob Proteins. 2015 Dec;7(4):249-58. doi: 10.1007/s12602-015-9199-1.
9
Comparative investigation of the various determinants that influence the codon and amino acid usage patterns in the genus Bifidobacterium.双歧杆菌属中影响密码子和氨基酸使用模式的各种决定因素的比较研究。
World J Microbiol Biotechnol. 2015 Jun;31(6):959-81. doi: 10.1007/s11274-015-1850-1. Epub 2015 Apr 5.
10
Protective effects of bifidobacterial adhesin on intestinal mucosa of stressed male rats via modulation of inflammation.双歧杆菌粘附素通过调节炎症对应激雄性大鼠肠黏膜的保护作用
Int J Clin Exp Pathol. 2014 May 15;7(6):3324-31. eCollection 2014.

本文引用的文献

1
Technical guidance - Update of the criteria used in the assessment of bacterial resistance to antibiotics of human or veterinary importance.技术指南——更新用于评估对人用或兽用重要抗生素的细菌耐药性的标准。
EFSA J. 2008 Jul 14;6(7):732. doi: 10.2903/j.efsa.2008.732. eCollection 2008 Jul.
2
Complete genome sequence of Bifidobacterium longum JDM301.长双歧杆菌 JDM301 的全基因组序列。
J Bacteriol. 2010 Aug;192(15):4076-7. doi: 10.1128/JB.00538-10. Epub 2010 Jun 4.
3
Safety and functional aspects of pre-selected lactobacilli for probiotic use in Iberian dry-fermented sausages.用于伊比利亚干发酵香肠的预筛选益生菌乳酸菌的安全性和功能特性
Meat Sci. 2009 Nov;83(3):460-7. doi: 10.1016/j.meatsci.2009.06.027. Epub 2009 Jun 21.
4
DnaK from Bifidobacterium animalis subsp. lactis is a surface-exposed human plasminogen receptor upregulated in response to bile salts.乳双歧杆菌亚种 DnaK 是一种表面暴露的人纤溶酶原受体,对胆盐有应答性地上调。
Microbiology (Reading). 2010 Jun;156(Pt 6):1609-1618. doi: 10.1099/mic.0.038307-0. Epub 2010 Feb 18.
5
Mucosal adhesion properties of the probiotic Lactobacillus rhamnosus GG SpaCBA and SpaFED pilin subunits.益生菌鼠李糖乳杆菌 GG SpaCBA 和 SpaFED 菌毛亚单位的黏膜黏附特性。
Appl Environ Microbiol. 2010 Apr;76(7):2049-57. doi: 10.1128/AEM.01958-09. Epub 2010 Jan 29.
6
The Bifidobacterium dentium Bd1 genome sequence reflects its genetic adaptation to the human oral cavity.齿双歧杆菌 Bd1 基因组序列反映了其对人类口腔的遗传适应性。
PLoS Genet. 2009 Dec;5(12):e1000785. doi: 10.1371/journal.pgen.1000785. Epub 2009 Dec 24.
7
Direct measurement of Mycobacterium-fibronectin interactions.直接测量分枝杆菌与纤维连接蛋白的相互作用。
Integr Biol (Camb). 2009 Apr;1(4):296-300. doi: 10.1039/b901396b. Epub 2009 Mar 3.
8
A case of D-lactic acid encephalopathy associated with use of probiotics.一例与使用益生菌相关的D-乳酸脑病病例。
Brain Dev. 2010 Sep;32(8):691-4. doi: 10.1016/j.braindev.2009.09.024. Epub 2009 Nov 14.
9
Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis.益生菌可降低早产儿患坏死性小肠结肠炎的风险:一项荟萃分析。
Neonatology. 2010;97(2):93-9. doi: 10.1159/000235684. Epub 2009 Aug 25.
10
Comparison of the complete genome sequences of Bifidobacterium animalis subsp. lactis DSM 10140 and Bl-04.动物双歧杆菌乳亚种DSM 10140与Bl-04全基因组序列的比较。
J Bacteriol. 2009 Jul;191(13):4144-51. doi: 10.1128/JB.00155-09. Epub 2009 Apr 17.